Embolization with more diluted glue-lipiodol in patients with massive hemoptysis: single center experience results

Basit Öğe Kaydı
dc.authoriddere, osman/0000-0001-8346-9477
dc.authorwosidYıldırım, İsmail Okan/AFR-8243-2022
dc.authorwosidDere, Osman/AAA-2247-2021
dc.contributor.authorKolu, M.
dc.contributor.authorKurtulus, S.
dc.contributor.authorDere, O.
dc.contributor.authorYurttutan, N.
dc.contributor.authorYildirim, I. O.
dc.date.accessioned2024-08-04T20:51:46Z
dc.date.available2024-08-04T20:51:46Z
dc.date.issued2022
dc.departmentİnönü Üniversitesien_US
dc.description.abstractOBJECTIVE: The aim of the study was to demonstrate the efficacy and safety of bronchial artery embolization (BAE) with more diluted N-butyl -2-cyanoacrylate (NBCA) in patients with massive hemoptysis. PATIENTS AND METHODS: In this retrospective study, there are 48 patients who underwent NBCA and BAE for massive hemoptysis between March 2018 and September 2021. Demographic data, technical and clinical results, immediate hemoptysis control, recurrent hemoptysis and complications were evaluated. RESULTS: The technical success rate and immediate hemoptysis control were achieved in 97.9% and 93.7%, respectively. The 3 patients who were exitus within the first 10 days were removed from the follow-up range. During the follow-up period (range, 5 months-42 months; median, 27.5 months), recurrent hemoptysis was found in 3 of the 45 patients (6.6 %). Since 1 patient refused and one patient died within the first 24 hours, repeated BAE procedures were performed in 4 patients. A total of 55 sessions of BAE with NBCA was performed to 48 patients. The underlying diseases causing hemoptysis were determined to be bronchiectasis (n=16), tuberculosis (n=8), neoplasm (n=7), aspergilloma (n=3), and arteriovenous malformation (n=2). In 4 patients, bronchiectasis and tuberculosis were present together and in 8 patients, the cause could not be specified. CONCLUSIONS: In conclusion, BAE with more diluted NBCA is a safe and effective embolization method. In addition, the use of more diluted NBCA reduces the recurrence rates in patients with hemoptysis.en_US
dc.identifier.endpage1548en_US
dc.identifier.issn1128-3602
dc.identifier.issue5en_US
dc.identifier.pmid35302198en_US
dc.identifier.scopus2-s2.0-85126659293en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage1543en_US
dc.identifier.urihttps://hdl.handle.net/11616/100544
dc.identifier.volume26en_US
dc.identifier.wosWOS:000771549500016en_US
dc.identifier.wosqualityQ2en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherVerduci Publisheren_US
dc.relation.ispartofEuropean Review For Medical and Pharmacological Sciencesen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectBladder ruptureen_US
dc.subjectInterventional treatmenten_US
dc.subjectEmbolizationen_US
dc.titleEmbolization with more diluted glue-lipiodol in patients with massive hemoptysis: single center experience resultsen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu